PORADOSU ENRIQUE (Chief Science and Business Off) received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/13/2023ACC: 0001104659-23-003866
Officer· Chief Science and Business Off
Since Feb 2022
+115K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
115K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+115K
Price / share
—
Trade value
—
% of position
9.1%
1/12/2023
1.26M→1.37M
Total
Net shares
+115K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/12/2023 | A · Award | +115K | — | — | 9.1% | 1.26M | 1.37M |
| Total | +115K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported